Furthermore, the KIM1 peptide prevents numerous models of JNK-mediated disease including 6-hydroxydopamine-induced toxicity in the brain, Parkinson’s disease, ischemia/reperfusion injury of the heart, and cardiotoxicity model. Here, MAPK8 is linked to Parkinson disease.